1. Home
  2. IOVA vs OSBC Comparison

IOVA vs OSBC Comparison

Compare IOVA & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • OSBC
  • Stock Information
  • Founded
  • IOVA 2007
  • OSBC 1981
  • Country
  • IOVA United States
  • OSBC United States
  • Employees
  • IOVA N/A
  • OSBC N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • OSBC Major Banks
  • Sector
  • IOVA Health Care
  • OSBC Finance
  • Exchange
  • IOVA Nasdaq
  • OSBC Nasdaq
  • Market Cap
  • IOVA 771.4M
  • OSBC 770.5M
  • IPO Year
  • IOVA N/A
  • OSBC N/A
  • Fundamental
  • Price
  • IOVA $1.98
  • OSBC $16.71
  • Analyst Decision
  • IOVA Buy
  • OSBC Buy
  • Analyst Count
  • IOVA 10
  • OSBC 5
  • Target Price
  • IOVA $12.22
  • OSBC $20.00
  • AVG Volume (30 Days)
  • IOVA 11.2M
  • OSBC 182.9K
  • Earning Date
  • IOVA 08-07-2025
  • OSBC 07-16-2025
  • Dividend Yield
  • IOVA N/A
  • OSBC 1.44%
  • EPS Growth
  • IOVA N/A
  • OSBC N/A
  • EPS
  • IOVA N/A
  • OSBC 1.83
  • Revenue
  • IOVA $212,679,000.00
  • OSBC $275,720,000.00
  • Revenue This Year
  • IOVA $86.62
  • OSBC $21.45
  • Revenue Next Year
  • IOVA $69.95
  • OSBC $12.41
  • P/E Ratio
  • IOVA N/A
  • OSBC $9.12
  • Revenue Growth
  • IOVA 11070.12
  • OSBC 2.88
  • 52 Week Low
  • IOVA $1.64
  • OSBC $13.71
  • 52 Week High
  • IOVA $12.51
  • OSBC $19.46
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 43.44
  • OSBC 50.77
  • Support Level
  • IOVA $1.95
  • OSBC $16.55
  • Resistance Level
  • IOVA $2.47
  • OSBC $17.08
  • Average True Range (ATR)
  • IOVA 0.15
  • OSBC 0.34
  • MACD
  • IOVA 0.05
  • OSBC -0.03
  • Stochastic Oscillator
  • IOVA 35.53
  • OSBC 44.64

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About OSBC Old Second Bancorp Inc.

Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.

Share on Social Networks: